95
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Danish Atrial Fibrillation Registry: A Multidisciplinary National Pragmatic Initiative for Monitoring and Supporting Quality of Care Based on Data Retrieved from Administrative Registries

ORCID Icon, , , ORCID Icon, , ORCID Icon, , , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 1259-1272 | Received 06 Oct 2023, Accepted 09 Dec 2023, Published online: 21 Dec 2023

References

  • Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482. doi:10.1136/bmj.i4482
  • Vinter N, Huang Q, Fenger-Gron M, Frost L, Benjamin EJ, Trinquart L. Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham heart study): community based cohort study. BMJ. 2020;370:m2724.
  • Burdett P, Lip GYH. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. 2022;8:187–194. doi:10.1093/ehjqcco/qcaa093
  • Johnsen SP, Dalby LW, Tackstrom T, Olsen J, Fraschke A. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017;17:714. doi:10.1186/s12913-017-2652-y
  • Hindricks G, Potpara T, Dagres N, et al. ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
  • Arbelo E, Aktaa S, Bollmann A, et al. Quality indicators for the care and outcomes of adults with atrial fibrillation. Europace. 2021;23(4):494–495. doi:10.1093/europace/euaa253
  • Heidenreich PA, Solis P, Mark ENA, et al. ACC/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American college of cardiology/American heart association task force on performance measures. Circ Cardiovasc Qual Outcomes. 2016;9:443–488. doi:10.1161/HCQ.0000000000000018
  • Heidenreich PA, Estes NAM, Fonarow GC, et al. Update to the 2016 ACC/aha clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American college of cardiology/American heart association task force on performance measures. J Am Coll Cardiol. 2021;77:326–341. doi:10.1016/j.jacc.2020.08.037
  • Batra G, Aktaa S, Camm AJ, et al. Data standards for atrial fibrillation/flutter and catheter ablation: the European unified registries for heart care evaluation and randomized trials (EuroHeart). Eur Heart J Qual Care Clin Outcomes. 2022.9:609–620.
  • Christesen AMS, Vinter N, Mortensen LS, Fenger-Gron M, Johnsen SP, Frost L. Inequality in oral anticoagulation use and clinical outcomes in atrial fibrillation: a Danish nationwide perspective. Eur Heart J Qual Care Clin Outcomes. 2018;4(3):189–199. doi:10.1093/ehjqcco/qcy011
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S179083
  • Shroff GR, Solid CA, Herzog CA. Atrial fibrillation, stroke, and anticoagulation in medicare beneficiaries: trends by age, sex, and race, 1992–2010. J Am Heart Assoc. 2014;3(3):e000756. doi:10.1161/JAHA.113.000756
  • Hansen PW, Sehested TSG, Fosbol EL, et al. Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011. PLoS One. 2018;13:e0194295.
  • Forslund T, Komen JJ, Andersen M, et al. Improved stroke Prevention in Atrial fibrillation after the introduction of non-vitamin k antagonist oral anticoagulants. Stroke. 2018;49(9):2122–2128. doi:10.1161/STROKEAHA.118.021990
  • Hohnloser SH, Basic E, Nabauer M. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database. Clin Res Cardiol. 2019;108(9):1042–1052. doi:10.1007/s00392-019-01437-7
  • Lee SR, Choi EK, Kwon S, et al. Effectiveness and safety of direct oral anticoagulants in relation to temporal changes in their use. Circ Cardiovasc Qual Outcomes. 2020;13(3):e005894. doi:10.1161/CIRCOUTCOMES.119.005894
  • Maggioni AP, Dondi L, Andreotti F, et al. Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million people. Am Heart J. 2020;220:12–19. doi:10.1016/j.ahj.2019.10.017
  • Cowan JC, Wu J, Hall M, Orlowski A, West RM, Gale CP. A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J. 2018;39(32):2975–2983. doi:10.1093/eurheartj/ehy411
  • Akao M, Ogawa H, Masunaga N, et al. 10-year trends of antithrombotic therapy status and outcomes in Japanese atrial fibrillation patients- the Fushimi AF registry. Circ J. 2022;86:726–736. doi:10.1253/circj.CJ-22-0023
  • Freixa-Pamias R, Blanch Gracia P, Rodriguez Latre ML, et al. Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke. Curr Med Res Opin. 2021;37(3):357–365. doi:10.1080/03007995.2020.1865892
  • Kennedy C, Gabr A, McCormack J, Collins R, Barry M, Harbison J. The association between increasing oral anticoagulant prescribing and atrial fibrillation related stroke in Ireland. Br J Clin Pharmacol. 2022;88(1):178–186. doi:10.1111/bcp.14938
  • Grymonprez M, Simoens C, Steurbaut S, De Backer TL, Lahousse L. Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis. Europace. 2022;24(6):887–898. doi:10.1093/europace/euab303
  • Qvist I, Lane DA, Risom SS, et al. Implementation of atrial fibrillation patient education. Eur J Cardiovasc Nurs. 2023;zvad066. doi:10.1093/eurjcn/zvad066
  • Rix TA, Riahi S, Overvad K, Lundbye-Christensen S, Schmidt EB, Joensen AM. Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry. Scand Cardiovasc J. 2012;46(3):149–153. doi:10.3109/14017431.2012.673728
  • Sundboll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish national patient registry: a validation study. BMJ Open. 2016;6:e012832.
  • Wildenschild C, Mehnert F, Thomsen RW, et al. Registration of acute stroke: validity in the Danish stroke registry and the Danish national registry of patients. Clin Epidemiol. 2014;6:27–36. doi:10.2147/CLEP.S50449
  • Han S, Jia R, Cen Z, et al. Early rhythm control vs. rate control in atrial fibrillation: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:978637. doi:10.3389/fcvm.2023.978637
  • Simader FA, Howard JP, Ahmad Y, et al. Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials. Europace. 2023;25(2):341–350. doi:10.1093/europace/euac173
  • Romiti GF, Pastori D, Rivera-Caravaca JM, et al. Adherence to the ‘atrial fibrillation better care’ pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost. 2022;122:406–414. doi:10.1055/a-1515-9630